FEZF1-AS1 upregulates PCK2 protein level by inhibiting proteasome-dependent degradation. Knocking out FEZF1-AS1 significantly reduces PCK2 protein level, leading to a decrease in mitochondrial energy metabolism and inhibiting the proliferation and migration of colorectal cancer cells. This evidence concerns the gene FEZF1 and colorectal cancer.